Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.5K Sell
215
-1,831
-89% -$128K ﹤0.01% 1683
2025
Q4
$136K Buy
2,046
+2,000
+4,348% +$129K ﹤0.01% 836
2025
Q3
$3.1K Sell
46
-600
-93% -$47.5K ﹤0.01% 1589
2025
Q2
$56.4K Buy
646
+624
+2,836% +$48.9K ﹤0.01% 999
2025
Q1
$1.5K Sell
22
-8
-27% -$653 ﹤0.01% 1549
2024
Q4
$2.31K Sell
30
-80
-73% -$5.92K ﹤0.01% 1554
2024
Q3
$7.35K Buy
110
+2
+2% +$164 ﹤0.01% 1390
2024
Q2
$12.2K Hold
108
﹤0.01% 1263
2024
Q1
$14.9K Hold
108
﹤0.01% 1249
2023
Q4
$13.4K Hold
108
﹤0.01% 1240
2023
Q3
$10K Hold
108
﹤0.01% 1281
2023
Q2
$13.8K Buy
108
+8
+8% +$968 ﹤0.01% 1210
2023
Q1
$11.6K Sell
100
-6
-6% -$672 ﹤0.01% 1242
2022
Q4
$12K Buy
106
+6
+6% +$659 ﹤0.01% 1291
2022
Q3
$8K Hold
100
﹤0.01% 1531
2022
Q2
$7K Hold
100
﹤0.01% 1685
2022
Q1
$13K Hold
100
﹤0.01% 1658
2021
Q4
$13K Buy
+100
New +$14.4K ﹤0.01% 1713

Other funds holding DXCM

Ancora Advisors's DXCM Position: Q1 2026 in Review

Ancora Advisors reduced its DexCom (DXCM) stake by 89% in Q1 2026, selling an estimated $128K and leaving 215 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1683.

Ancora Advisors first reported a position in DXCM in Q4 2021 and has held it in 18 quarters since. The position peaked at $136K in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Ancora Advisors held 215 shares of DexCom worth $13.5K as of Q1 2026.
  • Ancora Advisors sold 1,831 DexCom shares in Q1 2026, an estimated $128K.
  • DexCom made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #1683 holding.
  • Ancora Advisors first reported a position in DexCom in Q4 2021 and has held it in 18 quarters since.
  • Ancora Advisors's DexCom position peaked at $136K in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.